文献速递头颈甲状腺与浅表CT

双能CT衍生的动脉强化分数对甲状腺乳头状癌颈部淋巴结转移术前诊断的附加价值:初步结果

Added value of arterial enhancement fraction derived from dual-energy computed tomography for preoperative diagnosis of cervical lymph node metastasis in papillary thyroid cancer: initial results.
PubMed 文献 · Eur Radiol · 2023-08-17

本研究纳入92例甲状腺乳头状癌患者的273枚颈部淋巴结(153枚非转移、120枚转移),评估常规CT征象并计算单能CT衍生的动脉强化分数(AEFS)和双能CT衍生的动脉强化分数(AEFD)。转移性淋巴结的AEFD和AEFS均显著高于非转移性淋巴结,AEFD与AEFS相关性好且诊断性能相当;将常规CT征象与AEFS或AEFD联合可显著提高诊断性能。

要点

  • 转移性颈部淋巴结的AEFD和AEFS均显著高于非转移性淋巴结。
  • AEFD与AEFS相关性好(r=0.802),诊断性能相当(AUC 0.867 vs 0.852)。
  • 常规CT征象联合AEFS或AEFD可显著提高诊断颈部淋巴结转移的能力。

核心结论

  • AEFD与AEFS相关性好且性能相当;将定性CT图像特征与AEFS或AEFD整合可提高诊断甲状腺乳头状癌颈部淋巴结转移的能力。

研究设计与样本

  • 从92例甲状腺乳头状癌患者中纳入273枚颈部淋巴结(153枚非转移、120枚转移),评估淋巴结定性图像特征并计算AEFS和AEFD,采用前向变量选择的多因素logistic回归构建三个模型,用ROC曲线分析评估诊断性能。

关键影像表现/征象

  • 转移性淋巴结的AEFD为1.14,非转移性淋巴结为0.48(p<0.001)。
  • 转移性淋巴结的AEFS为1.08,非转移性淋巴结为0.38(p<0.001)。
  • 异常强化、钙化和囊性变被选入构建模型1。

诊断标准与关键数值

  • 模型1(常规特征:异常强化、钙化、囊性变)的AUC为0.675。
  • AEFD与AEFS相关性r=0.802(p<0.001),AEFD的AUC为0.867 vs AEFS的0.852(p=0.628)。
  • 模型2(常规特征+AEFS)AUC为0.865 vs 模型1的0.675(p<0.001)。
  • 模型3(常规特征+AEFD)AUC为0.883 vs 模型1的0.675(p<0.001)。

临床应用与阅片要点

  • AEF值(尤其是双能CT衍生的AEF)可帮助诊断甲状腺乳头状癌患者的颈部淋巴结转移,并补充常规CT图像特征以改善临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the added value of arterial enhancement fraction (AEF) derived from dual-energy computed tomography CT (DECT) to conventional image features for diagnosing cervical lymph node (LN) metastasis in papillary thyroid cancer (PTC).

METHODS: A total of 273 cervical LNs (153 non-metastatic and 120 metastatic) were recruited from 92 patients with PTC. Qualitative image features of LNs were assessed. Both single-energy CT (SECT)-derived AEF (AEFS) and DECT-derived AEF (AEFD) were calculated. Correlation between AEFD and AEFS was determined using Pearson's correlation coefficient. Multivariate logistic regression analysis with the forward variable selection method was used to build three models (conventional features, conventional features + AEFS, and conventional features + AEFD). Diagnostic performances were evaluated using receiver operating characteristic (ROC) curve analyses.

RESULTS: Abnormal enhancement, calcification, and cystic change were chosen to build model 1 and the model provided moderate diagnostic performance with an area under the ROC curve (AUC) of 0.675. Metastatic LNs demonstrated both significantly higher AEFD (1.14 vs 0.48; p < 0.001) and AEFS (1.08 vs 0.38; p < 0.001) than non-metastatic LNs. AEFD correlated well with AEFS (r = 0.802; p < 0.001), and exhibited comparable performance with AEFS (AUC, 0.867 vs 0.852; p = 0.628). Combining CT image features with AEFS (model 2) and AEFD (model 3) could significantly improve diagnostic performances (AUC, 0.865 vs 0.675; AUC, 0.883 vs 0.675; both p < 0.001).

CONCLUSIONS: AEFD correlated well with AEFS, and exhibited comparable performance with AEFS. Integrating qualitative CT image features with both AEFS and AEFD could further improve the ability in diagnosing cervical LN metastasis in PTC.

CLINICAL RELEVANCE STATEMENT: Arterial enhancement fraction (AEF) values, especially AEF derived from dual-energy computed tomography, can help to diagnose cervical lymph node metastasis in patients with papillary thyroid cancer, and complement conventional CT image features for improved clinical decision making.

KEY POINTS: • Metastatic cervical lymph nodes (LNs) demonstrated significantly higher arterial enhancement fraction (AEF) derived from dual-energy computed tomography (DECT) and single-energy CT (SECT)-derived AEF (AEFS) than non-metastatic LNs in patients with papillary thyroid cancer. • DECT-derived AEF (AEFD) correlated significantly with AEFS, and exhibited comparable performance with AEFS. • Integrating qualitative CT images features with both AEFS and AEFD could further improve the differential ability.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Xu YK, Geng D, et al. Added value of arterial enhancement fraction derived from dual-energy computed tomography for preoperative diagnosis of cervical lymph node metastasis in papillary thyroid cancer: initial results. Eur Radiol. 2023. PMID: 37589903. doi:10.1007/s00330-023-10109-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。